|
1 Indications And Usage Tymlos Is Indicated For The Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture Defined As A History Of Osteoporotic Fracture, Multiple Risk Factors For Fracture, Or Patients Who Have Failed Or Are Intolerant To Other Available Osteoporosis Therapy. In Postmenopausal Women With Osteoporosis, Tymlos Reduces The Risk Of Vertebral Fractures And Nonvertebral Fractures [See Clinical Studies ( 14 )] . Limitations Of Use Because Of The Unknown Relevance Of The Rodent Osteosarcoma Findings To Humans, Cumulative Use Of Tymlos And Parathyroid Hormone Analogs (E.g., Teriparatide) For More Than 2 Years During A Patient’s Lifetime Is Not Recommended [See Warnings And Precautions ( 5.1 )]. Tymlos Is A Human Parathyroid Hormone Related Peptide [Pthrp(1-34)] Analog Indicated For The Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture. ( 1 )
|